FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AMLJad Othman, Richard Dillon, Anjum Khan et al.|Leukemia|2023Cited by 48
Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortiumCristina Astrid Tentori, David A. Sallman, Lin P. Zhao et al.|HemaSphere|2024Cited by 11